This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JACC Interventions Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Webb, J. G. Search for Related Content PubMed Articles by Webb, J. G.

Percutaneous Aortic Valve Replacement Will Become a Common Treatment for Aortic Valve Disease

Division of Cardiology, St. Paul’s Hospital, University of British Columbia, Vancouver, Canada.

^_* Reprint requests and correspondence: Dr. John G. Webb, Director Cardiac Catheterization, St. Paul’s Hospital, 1081 Burrard Street, Vancouver, British Columbia V6Z 1Y6, Canada. (Email: webb{at}providencehealth.bc.ca).

Percutaneous valve replacement is developing into an effective and reproducible therapy for aortic valve stenosis. Initial experience suggests that outcomes compare favorably with conventional valve surgery in selected patients with comorbidities, such as advanced age. Caution is prudent, however, in the future a more mature procedure might represent a viable alternative for a much broader range of patients.

Abbreviations and Acronyms   EuroSCORE = European System for Cardiac Operative Risk Evaluation   PAVR = percutaneous aortic valve replacement

Related articles in JACC Interventions:

Aortic Stenosis: A Fatal Disease With But a Single Cure

Blase A. Carabello
JACC Interventions 2008 1: 127-128. [Full Text]  

This article has been cited by other articles:

				B. A. Carabello Aortic Stenosis: A Fatal Disease With But a Single Cure J. Am. Coll. Cardiol. Intv., April 1, 2008; 1(2): 127 - 128. [Full Text] [PDF]